[Skip to Navigation]
October 1969

Intravenous Glucose Tolerance Test in Depression

Author Affiliations

New Haven, Conn
From the Department of Psychiatry, Yale University School of Medicine, and the Connecticut Mental Health Center, New Haven, Conn.

Arch Gen Psychiatry. 1969;21(4):470-477. doi:10.1001/archpsyc.1969.01740220086010

REPORTS on glucose utilization in depressive illness, as measured by the intravenous glucose tolerance test (GTT), are in conflict. In 1958 pryce1,2 reported that depressed patients had lower glucose utilization rates (k) than normal subjects. This lowered k was not related to loss of body weight, and it did not change significantly following successful treatment with electroconvulsive therapy (ECT). Herzberg et al in 19683 reported, however, no clear association between depression and lowered oral or intravenous GTT. These authors reported no significant change in glucose utilization rate following recovery whether ECT, tryptophan, or no somatic treatment was employed. They attributed previously reported positive findings of the GTT in depression to either malnutrition or inactivity. Pryce's data were more consistent with the report by Van Praag and Leijnse in 19654 6 where decreased glucose utilization, as measured by forearm arteriovenous glucose difference, was associated with depressive illness.

Add or change institution